“generic-drugs” Archives

in
Entry Author Date Location
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More 10/18/19 National
Drug Pricing: Innovation, Investment, and the Public Good 09/24/19 Boston
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M 09/12/19 San Francisco
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More 08/02/19 National
Upjohn & Mylan to Merge, Freeing Pfizer to Focus on Biopharma R&D 07/29/19 New York
Bio Roundup: Merger Drama, FDA Trauma, Big IPOs, CRISPR Fights & More 06/28/19 National
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More 05/17/19 National
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More 04/26/19 National
Senators Grill Pharmacy Benefit Execs About Skyrocketing Drug Prices 04/09/19 National
FDA Panel Backs Amgen Bone Drug, Says Benefits Outweigh Heart Risks 01/16/19 National
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More 01/11/19 National
Bio Roundup: Eli Lilly Tries Tau, Generic Insulin, NASH Cash & More 12/14/18 National
Senators Grill HHS’s Azar on Drug Price Cuts That Have Yet to Come 06/26/18 National
Trump Pledges Lower Drug Prices, But Blueprint Is Short on Details 05/11/18 National
Exact Sciences, Generic Drugs, WEDC & More: This Week’s WI Watchlist 01/26/18 Wisconsin
Bio Roundup: Trump, Gottlieb, Gene Therapy Prices, IPO Hopes & More 01/05/18 National
Drug Prices, Industry Ties Take Spotlight at HHS Nominee Azar Hearing 11/29/17 National
Bio Roundup: Nobel Pursuit, Fundraising Fruit, A Rhythmic IPO & More 10/06/17 National
Bio Roundup: Senate Drama, A.I. Stories, Data Dives, Shkreli & More 06/30/17 National
Pernix Buyout Ends Generic Nightmare for Sleeping Pill Maker Somaxon 12/12/12 San Diego
San Diego Life Sciences Roundup: Santarus, Shire, Illumina, & More 09/06/12 San Diego
Momenta, Baxter Team Up on Biosimilars 12/23/11 Boston
Under Generic Pressure, San Diego’s Somaxon Looks for New Options 12/20/11 National
Forest Labs Snaps Up Clinical Data for $1.2B 02/22/11 Boston
How Much Would You Pay for Genzyme? 07/26/10 Boston
Arena Signs Deal With Eisai for Lorcaserin, Qualcomm CEO Identifies Two Opportunities in Mobile Health, & More San Diego Life Sciences News 07/08/10 San Diego
Silverlink Makes A Science of Healthcare Communication 07/27/09 Boston
Page 1 of 1